Log In
Print
BCIQ
Print
Print this Print this
 

PT001

  Manage Alerts
Collapse Summary General Information
Company Pearl Therapeutics Inc.
DescriptionGlycopyrrolate, a long-acting muscarinic antagonist (LAMA) delivered via a metered-dose hydrofluoroalkane (HFA) inhaler
Molecular Target Muscarinic receptor
Mechanism of Action 
Latest Stage of DevelopmentPhase II
IndicationChronic obstructive pulmonary disease (COPD)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today